Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C1864663 (
HCC
)
2,985
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In mammals, FOXO transcriptional factors form a family of four members (FOXO1, 3, 4, and 6) involved in the modulation proliferation, apoptosis, and carcinogenesis. The role of the FOXO family in breast cancer remains poorly elucidated. According to the cellular context and the stage of the disease, FOXOs can have opposite effects on carcinogenesis. To study the role of FOXOs in breast carcinogenesis in more detail, we examined their expression in normal tissues, breast cell lines, and a large series of breast tumours of human origin. We found a very low physiological level of
FOXO6
expression in normal adult tissues and high levels of expression in foetal brain.
FOXO
gene expressions fluctuate specifically in breast cancer cells compared to normal cells, suggesting that these genes may have different roles in breast carcinogenesis. For the first time, we have shown that, among the various
FOXO
genes, only
FOXO6
was frequently highly overexpressed in breast cell lines and tumours. We also found that inhibition of the endogenous expression of
FOXO6
by a specific siRNA inhibited the growth of the human breast cell lines MDA-MB-468 and
HCC
-38. FACS and Western blot analysis showed that inhibition of endogenous expression of
FOXO6
induced accumulation of cells in G0/G1 phase of the cell cycle, but not apoptosis. These results tend to demonstrate that the overexpression of the human
FOXO6
gene that we highlighted in the breast tumors stimulates breast carcinogenesis by activating breast cancer cell proliferation.
...
PMID:Involvement of the FOXO6 transcriptional factor in breast carcinogenesis. 2948 24